Doctor profile · Federal record
Dr. MUHAMMAD ISHAQ, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Internal Medicine Physician · OKLAHOMA CITY, OK
- NPI 1134449242
- Accepts Medicare
- MIPS 85.7 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5224 E I 240 SERVICE RD FL 2
OKLAHOMA CITY, OK 731352607
(405) 608-3800
fax (405) 608-3838
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- February 13, 2017
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Oklahoma #27815
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134449242. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,905
Distinct HCPCS
10
Medicare allowed
$308,433
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 726 | 219 | $112 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 620 | 178 | $74 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 595 | 313 | $119 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 196 | 185 | $162 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 159 | 159 | $155 | |
99291 |
Critical care, first 30-74 minutes | 123 | 51 | $205 | |
G0408 |
Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | 120 | 45 | $99 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 77 | 74 | $10 | |
94726 |
Test to determine lung volumes using sensors | 72 | 69 | $11 | |
94729 |
Test to examine how well the lungs exchange gases | 70 | 69 | $8 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 111. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$1,732
Transactions
89
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $396.31 | |
| GENZYME CORPORATION | 10 | $253.48 | |
| GlaxoSmithKline, LLC. | 27 | $227.10 | |
| AstraZeneca Pharmaceuticals LP | 7 | $214.37 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $180.73 | |
| Baxter Healthcare | 5 | $107.48 | |
| Novartis Pharmaceuticals Corporation | 5 | $92.60 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $57.48 | |
| INOGEN, INC. | 3 | $54.28 | |
| Actelion Pharmaceuticals US, Inc. | 3 | $49.34 | |
| Amgen Inc. | 1 | $24.34 | |
| Grifols USA, LLC | 1 | $22.75 | |
| Merck Sharp & Dohme LLC | 1 | $18.77 | |
| Fisher & Paykel Healthcare Inc | 1 | $17.52 | |
| Philips North America LLC | 1 | $15.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,962
Patients
670
Total drug cost
$887,483
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 555 | 142 | $488,138 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 266 | 93 | $8,751 |
| Nystatin | Generic | 171 | 76 | $1,957 |
| Montelukast Sodium | Generic | 145 | 48 | $2,444 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 134 | 43 | $104,516 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 115 | 41 | $72,203 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 114 | 28 | $63,201 |
| Fluticasone Propionate | Generic | 80 | 46 | $1,926 |
| Prednisone | Generic | 80 | 49 | $358 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 74 | 29 | $42,403 |